Litmus, the leading Industrial Edge Data Platform, today announced additional strategic funding from Insight Partners and Munich Re Ventures via HSB Fund II. The capital infusion will advance Litmus’ mission to make industrial data instantly accessible, contextualized, and AI-ready across global manufacturing enterprises.

“Litmus is addressing one of the hardest challenges in modern manufacturing—enabling Industrial AI on fragmented data,” said Josh Fredberg, Managing Director at Insight Partners. “We’re backing one of the only platforms that truly bridges OT and IT data at scale and turns that capability into measurable outcomes.”

Read More – Flux Marine Raises $15M in Funding

Litmus has become the data foundation for the world’s largest manufacturers, connecting machines, systems, and cloud environments through the broadest native OT connectivity in the industry—with over 250 out-of-the-box connectors. Its long-standing collaborations with Microsoft Azure, Google Cloud, AWS, and Dell Technologies expanded in 2025 with new partnerships with Oracle Cloud and Databricks, creating one of the most connected edge-to-cloud ecosystem in industrial data.

Recognized by Gartner as a Challenger in the 2025 Magic Quadrant™ for Global Industrial IoT Platforms, Litmus now powers unified data infrastructure across thousands of plants worldwide—turning raw machine signals into governed, contextualized, and AI-ready data that fuels real-time intelligence and decision-making.

“AI is only as powerful as the data it runs on, and Litmus makes operational data ready anywhere it lives,” said Stephanie Watkins, SVP of HSB’s Global Insurance Innovation Group. “Through this partnership we’re exploring how real-time industrial data can transform risk management, enabling proactive equipment health monitoring, predictive maintenance insights, and data-driven risk assessment that benefits both manufacturers and insurers.”

Litmus enables centralized management and multi-site scalability, allowing manufacturers to expand from one to five or more factories within weeks—all managed from a single, unified platform. This proven speed and scale are setting a new benchmark in the industry for enterprise-wide Industrial AI.

Read More – MindImmune Therapeutics Closes $10.2M Series A Extension; Brings Round Total to $30M